Log In
BCIQ
Print this Print this
 

E209

  Manage Alerts
Collapse Summary General Information
Company University of Liverpool
DescriptionA tetraoxane-based second generation antimalarial compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMalaria
Indication DetailsTreat malaria
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/05/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today